Facebook tracking pixel
K82.A1
ICD-10-CM
Biliary Dyskinesia

Learn about biliary dyskinesia (gallbladder dyskinesia), a functional gallbladder disorder. This resource provides information on diagnosis, including biliary dyskinesia symptoms, HIDA scan interpretation, and associated ICD-10 and CPT codes for accurate clinical documentation and medical coding. Find details on gallbladder ejection fraction and its role in identifying this functional disorder. Understand the clinical significance of biliary dyskinesia and available treatment options.

Also known as

Gallbladder Dyskinesia
Functional Gallbladder Disorder

Diagnosis Snapshot

Key Facts
  • Definition : Impaired gallbladder contraction leading to improper bile flow.
  • Clinical Signs : Upper abdominal pain, nausea, vomiting, bloating, often after fatty meals.
  • Common Settings : Outpatient gastroenterology clinics, diagnostic imaging centers.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC K82.A1 Coding
K82.8

Other specified diseases of gallbladder

Covers other specified gallbladder disorders, including dyskinesia.

K80-K87

Diseases of the biliary tract

Encompasses various biliary tract disorders, including gallbladder issues.

R10-R19

Symptoms and signs involving the digestive system and abdomen

Includes abdominal pain and other digestive symptoms that may accompany biliary dyskinesia.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Documented biliary dyskinesia/gallbladder dyskinesia?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Impaired gallbladder emptying.
Gallstones present in gallbladder.
Gallbladder inflammation.

Documentation Best Practices

Documentation Checklist
  • Document gallbladder ejection fraction (GBEF) from HIDA scan.
  • Record patient symptoms (e.g., nausea, pain after eating).
  • Note duration and frequency of biliary pain episodes.
  • Rule out other biliary pathologies with imaging/lab tests.
  • Specify diagnostic criteria used (e.g., Rome IV).

Coding and Audit Risks

Common Risks
  • Unspecified Dyskinesia

    Coding Biliary Dyskinesia without specifying the type (e.g., sphincter of Oddi) may lead to claim denials or underpayment. Consider K83.89.

  • Symptom Coding

    Avoid coding symptoms (e.g., abdominal pain, nausea) if Biliary Dyskinesia is confirmed. Focus on K82.8 instead of R10.4 or other symptom codes.

  • Supporting Documentation

    Lack of sufficient documentation (e.g., HIDA scan results, symptom correlation) can increase audit risk and claim rejection for Biliary Dyskinesia diagnosis.

Mitigation Tips

Best Practices
  • ICD-10 K82.8, K80-K87: Document gallbladder ejection fraction (GBEF) for accurate coding.
  • CDI: Query physician for specific symptoms like nausea, vomiting, and postprandial pain.
  • HCC coding: Link biliary dyskinesia to chronic conditions for risk adjustment.
  • Compliance: Ensure pre-authorization for HIDA scan per payer guidelines.
  • Best practice: Evaluate for alternative diagnoses like sphincter of Oddi dysfunction.

Clinical Decision Support

Checklist
  • Confirm episodic RUQ pain matching biliary colic.
  • Document gallbladder ejection fraction <35% via HIDA scan.
  • Exclude alternative diagnoses: gallstones, structural abnormalities.
  • Correlate symptoms with fatty food consumption or large meals.
  • Evaluate patient for other functional GI disorders.

Reimbursement and Quality Metrics

Impact Summary
  • Biliary dyskinesia reimbursement hinges on accurate ICD-10 coding (K82.8) and supporting documentation of ejection fraction.
  • Coding errors impact gallbladder dyskinesia reimbursement, leading to denials and reduced hospital revenue.
  • Quality metrics for biliary dyskinesia include symptom improvement, HIDA scan results, and patient satisfaction.
  • Accurate coding and documentation improve biliary dyskinesia data reporting for quality improvement initiatives.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the most effective diagnostic strategies for differentiating biliary dyskinesia from other biliary tract disorders mimicking its symptoms?

A: Diagnosing biliary dyskinesia can be challenging due to its symptomatic overlap with other conditions like gallstones or chronic cholecystitis. A key diagnostic tool is a hepatobiliary iminodiacetic acid (HIDA) scan with cholecystokinin (CCK) stimulation. This assesses gallbladder ejection fraction (EF), with an EF below 35% often suggestive of biliary dyskinesia. However, it's crucial to consider this in conjunction with the patient's symptoms. A low EF without corresponding biliary pain is not diagnostic. Other tests like abdominal ultrasound, endoscopic retrograde cholangiopancreatography (ERCP), and magnetic resonance cholangiopancreatography (MRCP) can help rule out structural abnormalities or gallstones. Furthermore, a thorough evaluation of the patient's medical history, including a detailed symptom assessment, is essential to differentiate biliary dyskinesia from other functional gastrointestinal disorders. Explore how incorporating standardized symptom scoring systems can enhance diagnostic accuracy. Consider implementing a multi-modal diagnostic approach, combining functional testing with imaging and clinical evaluation, for optimal patient management.

Q: How do I manage a patient presenting with suspected biliary dyskinesia who also has comorbid irritable bowel syndrome (IBS)?

A: The coexistence of biliary dyskinesia and irritable bowel syndrome (IBS) is relatively common, creating complexities in diagnosis and management due to overlapping symptoms. It's essential to first accurately diagnose biliary dyskinesia through appropriate testing, such as a HIDA scan with CCK stimulation, while simultaneously considering IBS diagnostic criteria based on the Rome IV criteria. Managing these conditions concurrently requires a holistic approach. Addressing lifestyle modifications, like dietary changes (e.g., low-FODMAP diet for IBS) and stress management techniques, can benefit both conditions. Pharmacological interventions for IBS, such as antispasmodics or antidepressants, may be necessary. For persistent biliary pain despite lifestyle changes, cholecystectomy may be considered, but it's crucial to have a thorough discussion with the patient about the potential benefits and risks, especially considering the functional nature of both disorders. Learn more about the efficacy of various therapeutic strategies for co-occurring biliary dyskinesia and IBS. Consider implementing a shared decision-making approach to personalize treatment plans and enhance patient outcomes.

Quick Tips

Practical Coding Tips
  • Code K82.8 for biliary dyskinesia
  • Document ejection fraction for diagnosis
  • Check medical necessity for biliary studies
  • Correlate symptoms with diagnostic tests
  • Consider ICD-10-CM specificity

Documentation Templates

Patient presents with symptoms consistent with biliary dyskinesia, also known as gallbladder dyskinesia or functional gallbladder disorder.  The patient reports experiencing episodic right upper quadrant pain, often postprandial, characterized as biliary colic or a dull ache.  Symptoms may include nausea, bloating, and indigestion.  No evidence of gallstones was found on abdominal ultrasound.  A hepatobiliary iminodiacetic acid (HIDA) scan with cholecystokinin (CCK) stimulation was performed to assess gallbladder ejection fraction (EF).  The patient's gallbladder EF was [insert value], which is [consistent with/inconsistent with] biliary dyskinesia diagnostic criteria. Differential diagnoses considered include sphincter of Oddi dysfunction, chronic acalculous cholecystitis, and gastroesophageal reflux disease (GERD).  Treatment options for biliary dyskinesia, including dietary modifications, pain management with medications such as antispasmodics, and the possibility of cholecystectomy, were discussed with the patient.  The risks and benefits of each treatment approach were explained, and the patient will follow up for further evaluation and management.  ICD-10 code K82.8 is considered for this encounter, depending on the final diagnosis.